Know Cancer

forgot password

Pain in Cancer Survivors

18 Years
Not Enrolling
Breast Cancer, Colorectal Cancer, Prostate Cancer, Head and Neck Cancer, Lung Cancer

Thank you

Trial Information

Pain in Cancer Survivors

The main objective of the proposed study is to identify the prevalence of persistent pain in
a sample of adult cancer survivors. Currently, there is a lack of comprehensive information
about pain in the cancer survivor population. Although prior studies have assessed pain
syndromes in breast and lung cancer survivors (e.g., post-mastectomy and post-thoracotomy
pain), there is a lack of information about the prevalence and characteristics of
post-treatment pain in other subpopulations of survivors. To address this knowledge gap, a
random sample of cancer survivors who are from 1 to 10 years post-treatment completion and
who were treated at Memorial Sloan-Kettering Cancer Center will complete a
telephone-administered pain interview and assessment battery focusing on pain, quality of
life, and psychological distress. Our initial recruitment and evaluation will begin in 50
breast cancer survivors and then will expand 50 survivors in each of the other services
Colorectal, Genitourinary, Head and Neck, and Thoracic in allotments of 50 participants
each. We estimate that the completion time for the interview and assessment battery will
range from 45 to 60 minutes. This telephone-based survey will identify vulnerable subgroups
of patients with persistent pain and provide a knowledge base for future research on the
prevalence and risk factors for post-treatment pain in the cancer survivor population.

Inclusion Criteria:

- Cancer treatment at MSKCC

- Are from 1 to 10 years post-treatment completion at the time of study recruitment

- No evidence of disease (NED) at the time of assessment;

- Over 18 years of age

- Can be reached by telephone

- Able to provide informed consent

- Able to speak and read English

- Cancer survivors who received adjuvant therapies outside MSKCC will be asked to
self-report the type and duration of cancer treatments received.

Exclusion Criteria:

- Undergoing active cancer treatment (ongoing tamoxifen use, hormone replacement
therapy or use of biologics are permitted)

- Evidence of encephalopathy, psychotic illness or cognitive impairment severe enough
to preclude giving informed consent to the study staff, or completing the survey
instruments of the study.

Type of Study:


Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Descriptive statistics will be generated to describe the prevalence of pain and its psychosocial correlates.

Outcome Time Frame:

1 to 10 years post-treatment completion

Safety Issue:


Principal Investigator

Steven Passik, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

May 2007

Completion Date:

January 2012

Related Keywords:

  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • breast cancer
  • Colorectal cancer
  • Prostate cancer
  • Head and Neck cancer
  • Lung cancer
  • cancer survivors
  • 07-068
  • quality of life
  • Pain in cancer survivors
  • Breast Neoplasms
  • Colorectal Neoplasms
  • Head and Neck Neoplasms
  • Lung Neoplasms
  • Prostatic Neoplasms



Memorial Sloan-Kettering Cancer CenterNew York, New York  10021